Industry / Brazil
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Embryonic Stem Cell Research Law Upheld
June 2008 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
In a major boost for Brazil's R&D credentials, the Supreme Court has voted to uphold the 2005 law permitting research using embryonic stem (ES) cells. Brazil will remain the first and only country in Latin America to allow the practice, following the narrow 6-5 vote in favour of the legislation. Research will be permitted on stem cells from embryos that have been frozen for at least three years and that have been deemed unsuitable for human reproduction, with the consent of the